Regenerative Medical Technology RMTG
OTC RMTG
$0.06 +0.00 (+0.00%)
At close: Sep 29, 2026 · 4:00 PM EDT

Regenerative Medical Technology (RMTG) Total Non-Current Liabilities (2021 - 2026)

Updated

Regenerative Medical Technology (RMTG) recorded Total Non-Current Liabilities of $41.87 million in Q2 2026, up 25.0% from $33.5 million a year earlier and up 4.6% from the prior quarter.

Analysis

Regenerative Medical Technology (RMTG) Total Non-Current Liabilities (2021 - 2026) Analysis & Trends

At the end of FY2025, Regenerative Medical Technology reported Total Non-Current Liabilities of $37.49 million, up 20.3% from FY2024.

  • Annual Total Non-Current Liabilities has increased for four straight years, with a four-year compound annual growth rate of 23.6% (FY2021 to FY2025).
  • Across earlier years, Total Non-Current Liabilities came in at $31.17 million in FY2024 (+26.3%), $24.67 million in FY2023 (+23.0%), $20.06 million in FY2022 (+25.0%) and $16.04 million in FY2021.
  • The Q2 2026 figure is the highest quarterly Total Non-Current Liabilities in data going back to Q4 2021.
  • On a year-over-year basis, Total Non-Current Liabilities has increased for 15 consecutive quarters, with growth averaging 21.0% over the last eight quarters.
  • Across the past five years, year-over-year growth in Total Non-Current Liabilities ran from 15.5% in Q3 2025 to 29.3% in Q3 2023.
  • Per Business Quant, the preceding three quarters came in at $40.05 million (Q1 2026), $37.49 million (Q4 2025) and $34.57 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 105.99 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 106.45 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 80.25 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 48.34 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -967.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 81.11 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 36.04 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 100.86 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 5.92 Bn
10 Regenerative Medical Technology 824,338.06 -3.70 Mn 2.58 Mn 41.87 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 41.87 Mn
Mar 31, 2026 40.05 Mn
Dec 31, 2025 37.49 Mn
Sep 30, 2025 34.57 Mn
Jun 30, 2025 33.50 Mn
Mar 31, 2025 32.09 Mn
Dec 31, 2024 31.17 Mn
Sep 30, 2024 29.94 Mn
Jun 30, 2024 28.88 Mn
Mar 31, 2024 26.83 Mn
Dec 31, 2023 24.67 Mn
Sep 30, 2023 24.85 Mn
Jun 30, 2023 23.22 Mn
Mar 31, 2023 21.71 Mn
Dec 31, 2022 20.06 Mn
Sep 30, 2022 19.22 Mn
Jun 30, 2022 19.36 Mn
Mar 31, 2022 17.12 Mn
Dec 31, 2021 16.04 Mn
API Access

Regenerative Medical Technology Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=RMTG&period=max&api_key=YOUR_API_KEY